XML 32 R25.htm IDEA: XBRL DOCUMENT v3.25.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
Summary of Cash and Cash Equivalents

This table provides a summary of cash and cash equivalents as presented on the Consolidated Statements of Cash Flows as of September 30, 2025 and September 30, 2024 (in thousands):

 

 

September 30,

 

 

 

2025

 

 

2024

 

Due from the FRB

 

$

7,768,405

 

 

$

6,498,695

 

Cash and due from banks

 

 

1,073,005

 

 

 

778,069

 

Cash and cash equivalents at end of period

 

$

8,841,410

 

 

$

7,276,764

 

 

Summary of Amounts Used in Determination of Basic and Diluted Net Income Per Common Share The following table provides the amounts used in the determination of basic and diluted net income per common share for the three and nine months ended September 30, 2025 and 2024 (in thousands, except share and per share data):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Net income

 

$

188,316

 

 

$

109,643

 

 

$

487,043

 

 

$

321,246

 

Less: Preferred dividends

 

 

7,944

 

 

 

 

 

 

11,969

 

 

 

 

Net income available to common shareholders

 

$

180,372

 

 

$

109,643

 

 

$

475,074

 

 

$

321,246

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding for basic earnings per share

 

 

75,943,943

 

 

 

48,775,072

 

 

 

72,349,952

 

 

 

48,727,914

 

Assumed incremental common shares issued upon vesting of outstanding restricted stock units

 

 

422,875

 

 

 

303,425

 

 

 

394,337

 

 

 

265,667

 

Weighted average common shares for diluted earnings per share

 

 

76,366,818

 

 

 

49,078,497

 

 

 

72,744,289

 

 

 

48,993,581

 

Net income per common share – basic

 

$

2.38

 

 

$

2.25

 

 

$

6.57

 

 

$

6.59

 

Net income per common share – diluted

 

 

2.36

 

 

 

2.23

 

 

 

6.53

 

 

 

6.56

 

Number of antidilutive restricted stock units excluded from diluted earnings per share computation

 

 

 

 

 

 

 

 

 

 

 

 

Number of antidilutive stock options excluded from diluted earnings per share computation

 

 

 

 

 

 

 

 

4,962